Curaleaf Holdings (CURLF) Net Cash Flow (QoQ) (2019 - 2024)
Curaleaf Holdings (CURLF) Net Cash Flow (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 537.11% |
| Sep 30, 2024 | 100.01% |
| Jun 30, 2024 | -200.01% |
| Mar 31, 2024 | 175,797.76% |
| Dec 31, 2023 | -175.24% |
| Sep 30, 2023 | -99.93% |
| Jun 30, 2023 | 199.84% |
| Mar 31, 2023 | -140,566.82% |
| Dec 31, 2022 | 229.95% |
| Sep 30, 2022 | -35.06% |
| Jun 30, 2022 | -147.29% |
| Mar 31, 2022 | 317.60% |
| Dec 31, 2021 | -28.22% |
| Sep 30, 2021 | -176.30% |
| Jun 30, 2021 | -92.06% |
| Mar 31, 2021 | 5,969.22% |
| Dec 31, 2020 | -20,406.55% |
| Sep 30, 2020 | 100.04% |
| Jun 30, 2020 | -139.98% |
| Mar 31, 2020 | 374.17% |